Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents
Open Access
- 1 June 2021
- Vol. 26 (11), 3327
- https://doi.org/10.3390/molecules26113327
Abstract
Phenanthroindolizidines, such as antofine and tylophorine, are a family of natural alkaloids isolated from different species of Asclepiadaceas. They are characterized by interesting biological activities, such as pronounced cytotoxicity against different human cancerous cell lines, including multidrug-resistant examples. Nonetheless, these derivatives are associated with severe neurotoxicity and loss of in vivo activity due to the highly lipophilic nature of the alkaloids. Here, we describe the development of highly polar prodrugs of antofine and tylophorine as hypoxia-targeted prodrugs. The developed quaternary ammonium salts of phenanthroindolizidines showed high chemical and metabolic stability and are predicted to have no penetration through the blood–brain barrier. The designed prodrugs displayed decreased cytotoxicity when tested under normoxic conditions. However, their cytotoxic activity considerably increased when tested under hypoxic conditions.Keywords
Funding Information
- King Abdulaziz City for Science and Technology (13-MED2515-10)
This publication has 48 references indexed in Scilit:
- Synthesis of substituted 5-bromomethyl-4-nitroimidazoles and use for the preparation of the hypoxia-selective multikinase inhibitor SN29966Tetrahedron, 2013
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in miceJCI Insight, 2010
- The tumor microenvironment and metastatic diseaseClinical & Experimental Metastasis, 2008
- Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseNature Reviews Cancer, 2008
- Structure–activity studies of phenanthroindolizidine alkaloids as potential antitumor agentsBioorganic & Medicinal Chemistry Letters, 2007
- Inhibition of cell growth and nuclear factor-κB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503Molecular Cancer Therapeutics, 2006
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Cryptopleurine - an inhibitor of translocationBiochemistry, 1976
- Antibiotics and compounds affecting translation by eukaryotic ribosomes. Specific enhancement of aminoacyl-tRNA binding by methylxanthinesMolecular and Cellular Biochemistry, 1976